Goldman Sachs analyst Richard Law lowered the firm’s price target on Rocket Pharmaceuticals (RCKT) to $15 from $29 and keeps a Neutral rating ...

Goldman Sachs has dropped an entire section dedicated to "diversity and inclusion" from its annual filing released on ...

(Reuters) - Goldman Sachs appointed Elizabeth Overbay as the chief financial officer of its asset and wealth management ...

In recent quarters, funding to companies in the legal and legal tech sectors has surged to levels comparable to what we saw ...

Goldman Sachs, which has been vocal about public commitments to diversity and inclusion, is shifting its stance, pointing to ...

Goldman Sachs Group Inc. erased diversity targets from a key regulatory filing, becoming the latest Wall Street firm to turn away from specific goals for a more representative workforce after an ...

Goldman Sachs Group Inc. erased diversity targets from a key regulatory filing, becoming the latest Wall Street firm to turn ...

Matt Levine is a Bloomberg Opinion columnist. A former investment banker at Goldman Sachs, he was a mergers and acquisitions lawyer at Wachtell, Lipton, Rosen & Katz; a clerk for the U.S. Court of ...

Robinson Bradshaw, one of Charlotte's largest law firms, is kicking off its 65th year in business with a major change.

Goldman Sachs is betting big on Dallas, Texas. Five employees, from partner to analyst, share what living and working there ...

We recently published a list of 10 Oversold Biotech Stocks to Buy Now. In this article, we are going to take a look at where MoonLake Immunotherapeutics (NASDAQ:MLTX) stands against the other oversold ...

AI benchmarking platform Evident has today launched its latest AI Use Case Tracker for banks and found that four institutions lead the way in this growing field. And the fact that major banks are ...